Skip to Main Content

Type 1 Diabetes Extension Study (T1DES)

Conditions

Children's Health | Diabetes Mellitus - Type 1

What is the purpose of this trial?

To further our understanding of the immunologic mechanisms underlying maintenance and loss of beta cell function by evaluating the relationship between longitudinal changes in beta cell function and changes over time in biomarkers known to be associated with a response to immune modulating treatments which were used in prior clinical trials (Refer to ClinicalTrials.gov records NCT00129259 and NCT00965458).

  • Trial with
    Benaroya Research Institute
  • Start Date
    05/06/2016
  • End Date
    03/01/2021

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #1512016925